Clinical Trials Directory

Trials / Completed

CompletedNCT00525772

Effect of Ciclesonide on Exercise Induced Bronchoconstriction

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Hamilton Health Sciences Corporation · Academic / Other
Sex
All
Age
12 Years – 30 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to study the effects of once daily inhaled ciclesonide at varying doses on exercise provoked asthma symptoms, fall in lung function after exercise and sputum characteristics.

Detailed description

To study the effects of 4 doses of ciclesonide on exercise-induced bronchoconstriction, bronchial responsiveness to mannitol, sputum parameters and other parameters of asthma control in asthmatic patients. The primary aim was to evaluate exercise-induced bronchoconstriction as a method of determining the dose and time responses of inhaled corticosteroid therapy. The secondary aims were to evaluate the dose and time responses of sputum parameters and responsiveness to mannitol to inhaled corticosteroid therapy. Furthermore to explore the relationship(s) between exercise induced bronchoconstriction, sputum parameters and mannitol responsiveness.

Conditions

Interventions

TypeNameDescription
DRUGciclesonidelow dose- 50ug and 200ug
DRUGciclesonidehigh dose- 100ug and 400ug

Timeline

Start date
2001-11-01
Primary completion
2007-11-01
Completion
2007-11-01
First posted
2007-09-06
Last updated
2009-10-21

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00525772. Inclusion in this directory is not an endorsement.